#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune haemolytic anaemia Iron overload Ocular myasthenia Hypersomnia Uveal melanoma Fatty acid oxidation disorder Chronic lymphocytic leukaemia recurrent Lupus nephritis Emphysema Eosinophilic granulomatosis with polyangiitis Chronic granulomatous disease Plasma cell myeloma refractory Carcinoid tumour Angelman's syndrome Myeloid leukaemia More trials…

    Learn about Rare Diseases

    Fragile X syndrome Cystic fibrosis lung – Treatment Sjogren’s syndrome – Life with Disease Sarcoidosis Stevens-Johnson syndrome – Treatment Prader-Willi syndrome – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Trials in Disease Angiosarcoma non-metastatic – Trials in Disease Rosai-Dorfman syndrome – Trials in Disease Nephrotic syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tianeptine Mps-102 BLEXIMENIB Rondaptivon Pegol Iptacopan FLUCLOXACILLIN SODIUM Tinzaparin Sodium Pembrolizumab Lasn01 Leucine Teriparatide Vinorelbine Soft Paraffin And Fat Products TTX-381 AUR200 ABY-271 Famotidine Obexelimab VHB937 Ranitidine Hydrochloride More therapies…

    Learn about Your Condition

    Oesophageal cancer metastatic Nasal sinus cancer Liposarcoma recurrent Hyperparathyroidism primary Nodular melanoma Encephalitis autoimmune Lichen sclerosus Androgenetic alopecia Neutropenia Vomiting Mucous membrane pemphigoid Primary biliary cholangitis Bacterial prostatitis Plasma cell myeloma recurrent Endometrial cancer stage I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on Stem Cell Transplantation and Immunotherapy with Rituximab, Dinutuximab Beta, and Drug Combination for Patients with High-Risk Relapsed Neuroblastoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • ALLOGENEIC PERIPHERAL BLOOD-DERIVED HAEMATOPOIETIC STEM CELLS, TCR ALPHA/BETA+ CD19+ DEPLETED
    • ALLOGENEIC PERIPHERAL BLOOD-DERIVED NK CELLS CD3- CD56+
    • Dinutuximab Beta
    Italy

  • Study on the Safety and Effectiveness of Parecoxib and Sodium Chloride for Patients Hospitalized with Spontaneous Subarachnoid Hemorrhage

    Recruiting

    2 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • PARECOXIB
    • Sodium Chloride
    Czechia

  • Study on the Safety and Effectiveness of Sirolimus and Vigabatrin for Preventing Symptoms in Infants with Tuberous Sclerosis Complex

    Recruiting

    4 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    • Epilepsy
    Investigated Drugs:
    • Vigabatrin
    • Sirolimus
    Poland

  • Study of apomorphine and rifaximin for Parkinson’s disease patients with reduced levodopa effectiveness

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Benserazide Hydrochloride
    • Domperidone
    • Rifaximin
    The Netherlands

  • Study on Acoramidis for Preventing Transthyretin Amyloidosis in Young People with a Genetic Risk

    Recruiting

    3 1
    Investigated Diseases:
    • Acquired ATTR amyloidosis
    Investigated Drugs:
    • Acoramidis Hydrochloride
    Belgium Bulgaria Denmark France Germany Greece +6

  • Study on the Effectiveness and Safety of Sirolimus for Patients with Drug-Resistant Epilepsy Linked to Tuberous Sclerosis Complex

    Recruiting

    3 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    • Epilepsy
    Investigated Drugs:
    • Sirolimus
    Poland
Previous Page
1 … 23 24 25 26 27 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!